ATYPICAL NEUROFIBROMA
Clinical trials for ATYPICAL NEUROFIBROMA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL NEUROFIBROMA trials appear
Sign up with your email to follow new studies for ATYPICAL NEUROFIBROMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could spot rare nerve tumors years earlier in NF1 patients
Knowledge-focused OngoingThis study is testing whether a blood test (liquid biopsy) can detect a rare but serious nerve tumor called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will compare the timing of tumor detection by the blood test versus standard i…
Matched conditions: ATYPICAL NEUROFIBROMA
Sponsor: David Miller • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New study aims to predict cancer risk in NF1 patients before it strikes
Knowledge-focused OngoingThis study follows 80 people with Neurofibromatosis type 1 (NF1) who are at high risk for developing malignant peripheral nerve sheath tumors (MPNST). Researchers will use yearly whole-body MRI scans, blood samples, and checkups to track changes in nerve lesions over time. The go…
Matched conditions: ATYPICAL NEUROFIBROMA
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC